FGFR- and EGFR-driven SHP2 activation displays differential sensitivity to allosteric SHP2 inhibition

Hao, HX; Lu, HY; Liu, C; LaMarche, M; Engelman, JA; Hammerman, PS; Caponigro, G

CANCER RESEARCH, 2019; 79 (13):